https://pubmed.ncbi.nlm.nih.gov/16465362/
Dendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced...
A pilot clinical trial using dendritomas, purified hybrids from the fusion of dendritic/tumor cells combined with a low dose of IL-2, in metastatic melanoma...